PRITI MODI: Open Payments
NPI 1568440246 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 44 payments from 21 companies in 2025. Trend: 2023 $978 · 2024 $1,541 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $181 |
| Novo Nordisk Inc | 1 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Lundbeck LLC | 3 | $67 |
| Lilly USA, LLC | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Viatris Specialty LLC | 2 | $45 |
| Amgen Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
Products named: REXULTI, JARDIANCE, Ozempic, Kerendia, MOUNJARO, TRELEGY ELLIPTA, YUPELRI, EVENITY.
Industry payments across CA — which companies pay providers there.
